Circulating gamma delta T cells rise with lumbar Modic changes
Chronic low back pain tied to lumbar Modic changes is usually discussed as a spinal imaging problem, but this preprint pushes the biology outward into the bloodstream. In a cohort of 37 surgical patients, investigators found that the γδ T cell compartment was the only immune population that expanded significantly in those with Modic lesions, compared with patients without Modic change. The median frequency rose from 0.58% of all recorded cells in non-MC donors to 1.61% in pooled MC samples, with an odds ratio of 2.38 and q = 0.035.
A spinal lesion pattern with a systemic immune signature
Modic changes are vertebral endplate and bone marrow lesions that accompany chronic low back pain, and they are often classified as either type 1, with an edema-like appearance, or type 2 or 3, with fat- and sclerosis-like features. Clinicians have long treated those categories as different phases of the same process, yet the underlying immunology has remained murky. This study adds a new layer: the lesion pattern is not only local to the spine. It is associated with a measurable shift in circulating immune cells, suggesting that vertebral inflammation and immune activation may be linked through a broader systemic circuit rather than a purely isolated endplate injury.
The signal centered on γδ T cells, a lymphocyte lineage that sits between innate and adaptive immunity and can respond rapidly to stress-associated antigens and tissue damage cues. That biology fits the disease context. Vertebral endplate injury, marrow edema, and chronic inflammatory signaling could all provide the kind of altered tissue environment that recruits or expands this subset, especially if local immune activation spills into the circulation or if circulating cells are primed by lesion-derived mediators.
Vδ2+ cells appear to drive the expansion
The flow cytometry work did not stop at the broad compartment. After clustering γδ T cells into subsets, the investigators found that the expansion was compartment-wide but primarily driven by Vδ2+ T cells. That matters because it narrows the immune signal from a general lymphocyte perturbation to a definable subset that may be more directly tied to antigen sensing, inflammatory trafficking, or tissue surveillance.
The data do not prove causation, and they do not establish whether Vδ2+ cells participate in generating pain, merely track with the lesion biology, or respond to an upstream inflammatory trigger that is itself unrelated to pain severity. Even so, the finding sharpens the hypothesis. If a specific γδ T-cell subset is repeatedly enriched in patients with Modic lesions, it becomes a plausible candidate for future mechanistic work in tissue, blood, and perhaps synovial or marrow-adjacent compartments.
Multi-marker immune mapping found additional leads, but no corrected signals
The study used a dense immune phenotyping strategy on peripheral blood mononuclear cells drawn from patients undergoing lumbar spinal surgery. Thirty-seven patients were divided into three groups: 11 with no Modic changes, 15 with MC1, and 11 with MC2 or MC3. Samples were fluorescently barcoded, pooled, and stained with a 28-antibody panel, then split into 30 aliquots for additional co-staining with antibodies against integrins, selectins, or chemokine receptors. Differences in abundance were tested with binomial mixed models adjusted for acquisition batch, age, and sex.
Several adhesion receptor differences emerged in the broader screen. Basophils showed α6 and α2 integrin, plasmacytoid dendritic cells expressed endoglin, and IgA-positive B cells expressed β7 integrin differently in Modic disease. None of those findings survived multiple-testing correction across the whole screen, so they remain exploratory rather than practice-changing. The strongest and most durable signal stayed with the γδ T cell compartment.
Why this immune pattern matters biologically
γδ T cells often expand in settings where tissue stress, barrier disruption, or sterile inflammation changes the immunologic terrain. In a vertebral lesion, chronic microdamage at the endplate could expose matrix fragments, alter local cytokine gradients, and create a marrow environment that favors activation of this lineage. The association with lumbar Modic changes is therefore biologically plausible, especially when set beside prior reports of γδ T-cell accumulation within MC1 lesions themselves.
The preprint explicitly links the blood finding to those earlier tissue observations. The circulating expansion aligns with lesion-level accumulation and supports a model in which γδ T cells participate in the pathophysiology of Modic-related pain rather than serving as a nonspecific marker of chronic illness. The relationship may reflect trafficking between blood and inflamed vertebral tissue, or a shared inflammatory program that is detectable in both compartments.
Surgical cohort, narrow window, and unanswered clinical use
The patient sample came from a surgical population, which means the immune profile may not map cleanly onto all patients with chronic low back pain or all stages of Modic disease. The cohort was also modest in size, and the study design was cross-sectional. Those features limit inference about disease progression, treatment response, or whether γδ T-cell expansion changes when lesions evolve from MC1 to MC2/3.
Still, the study offers a clear direction for future work. If blood-based γδ T-cell profiling can be replicated in larger and less selected cohorts, it could help define a systemic biomarker of Modic-associated disease biology. If the signal proves strongest in MC1, or tracks with inflammatory activity on imaging, it could also help distinguish active lesion biology from more chronic structural change. For now, the most defensible conclusion is narrower: lumbar Modic changes are accompanied by expansion of circulating γδ T cells, with Vδ2+ cells carrying much of that signal, and the immune signature deserves follow-up in longitudinal and tissue-based studies.